Technology
HCA Healthcare projects a significant profit drop due to a surge in uninsured patients after subsidy changes under the Affordable Care Act.
Technology
Anthropic's Claude Science software targets biopharma research, showcasing AI's positive potential amidst ongoing public skepticism.
Technology
The ex-Akero Therapeutics team has formed Avere Therapeutics, targeting immunology with an oral IL-23 inhibitor from a Chinese source.
Technology
Health workers in the DRC protest unpaid wages as Ebola cases rise, highlighting the urgent need for coordinated global health responses.
Finance
Dr. Jeremy Faust, a Boston emergency physician, uses his platform to blend urgent medical insights with broader health discussions, attracting a large audience.
Technology
This week's biotech podcast discusses rising health insurance costs and the whistleblower case against an insurer, alongside industry developments.
Technology
A significant cyclospora outbreak in Michigan has exceeded 1,000 cases, prompting investigations across several states as health officials seek the source.
Technology
The sharp rise in ACA marketplace premium costs significantly affects small businesses, raising new challenges in employee health benefits.
Technology
A father invests $70 million into developing a gene therapy for his daughter’s rare condition, seeking breakthroughs for patients like her.
Technology
The search for the next FDA commissioner heats up with notable contenders, while AstraZeneca's heart drug faces a major trial setback.
Technology
Recent research from OpenEvidence questions the effectiveness of large language models in health technology applications, presenting new insights into AI capabilities.
Technology
Recent studies suggest that psilocybin therapy may offer enduring relief for patients with depression, presenting a significant advancement in treatment options.
Technology
The decline of employer-based health insurance is straining workers and businesses, raising serious concerns about its sustainability.
Technology
A recent analysis of GLP-1 telehealth platforms reveals significant variation in service quality, highlighting the need for more regulated standards.
Finance
Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals for $10 billion, marking a pivotal expansion into rare disease treatments.